Yunjun Guo, Ph.D. - Publications
Affiliations: | Chemistry | Washington University, Saint Louis, St. Louis, MO |
Area:
Nucleic Acid ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Zeng D, Guo Y, White AG, Cai Z, Modi J, Ferdani R, Anderson CJ. Comparison of conjugation strategies of cross-bridged macrocyclic chelators with cetuximab for copper-64 radiolabeling and PET imaging of EGFR in colorectal tumor-bearing mice. Molecular Pharmaceutics. 11: 3980-7. PMID 24720806 DOI: 10.1021/Mp500004M | 0.663 | |||
2014 | Beaino W, Guo Y, Chang AJ, Anderson CJ. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 19: 427-38. PMID 24445997 DOI: 10.1007/S00775-013-1087-0 | 0.68 | |||
2013 | Guo Y, Parry JJ, Laforest R, Rogers BE, Anderson CJ. The role of p53 in combination radioimmunotherapy with 64Cu-DOTA-cetuximab and cisplatin in a mouse model of colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1621-9. PMID 23873478 DOI: 10.2967/Jnumed.112.118539 | 0.675 | |||
2012 | Guo Y, Ferdani R, Anderson CJ. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator. Bioconjugate Chemistry. 23: 1470-7. PMID 22663248 DOI: 10.1021/Bc300092N | 0.742 | |||
2010 | Guo Y, Zheleznyak A, Anderson CJ. Relationship between cisplatin, copper-64 radiopharmaceuticals and p53 in the trafficking of 64Cu to the nuclei of tumor cells Nuclear Medicine and Biology. 37: 706. DOI: 10.1016/J.Nucmedbio.2010.04.105 | 0.736 | |||
2010 | Ferdani R, Guo Y, Stigers D, Fiamengo AL, Wei L, Wong EH, Weisman GR, Anderson CJ. Synthesis, Cu(II) complexation, 64Cu-labeling and biological evaluation of CB-TE1A1P Nuclear Medicine and Biology. 37: 690. DOI: 10.1016/J.Nucmedbio.2010.04.048 | 0.39 | |||
Show low-probability matches. |